Exploring the proteasome system: A novel concept of proteasome inhibition and regulation

X Wang, T Meul, S Meiners - Pharmacology & Therapeutics, 2020 - Elsevier
The proteasome is a well-identified therapeutic target for cancer treatment. It acts as the
main protein degradation system in the cell and degrades key mediators of cell growth …

Proteasome inhibitors: harnessing proteostasis to combat disease

DJ Sherman, J Li - Molecules, 2020 - mdpi.com
The proteasome is the central component of the main cellular protein degradation pathway.
During the past four decades, the critical function of the proteasome in numerous …

The proteasome, a new target for cancer therapy

S Gillessen, M Groettup, T Cerny - Oncology Research and Treatment, 2002 - karger.com
The proteasome is a multicatalytic protease and the principal non-lysosomal proteolytic
system in all eukaryotic cells. It plays a central role in virtually all regulatory pathways as for …

The proteasome in modern drug discovery: second life of a highly valuable drug target

PM Cromm, CM Crews - ACS central science, 2017 - ACS Publications
As the central figure of the cellular protein degradation machinery, the proteasome is critical
for cell survival. Having been extensively targeted for inhibition, the constitutive proteasome …

The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges

GR Tundo, D Sbardella, AM Santoro, A Coletta… - Pharmacology & …, 2020 - Elsevier
Abstract Ubiquitin Proteasome System (UPS) is an adaptable and finely tuned system that
sustains proteostasis network under a large variety of physiopathological conditions. Its …

A practical review of proteasome pharmacology

TA Thibaudeau, DM Smith - Pharmacological reviews, 2019 - ASPET
The ubiquitin proteasome system (UPS) degrades individual proteins in a highly regulated
fashion and is responsible for the degradation of misfolded, damaged, or unneeded cellular …

Proteasome‐mediated proteostasis: novel medicinal and pharmacological strategies for diseases

R Mishra, A Upadhyay, VK Prajapati… - Medicinal research …, 2018 - Wiley Online Library
Proteins actively participate in a wide range of cellular physiological functions. But
aggregation of proteins results in cytotoxicity, and unwanted aggregation of misfolded …

Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy

M Frezza, S Schmitt, Q Ping Dou - Current topics in medicinal …, 2011 - ingentaconnect.com
Selective degradation of proteins by the ubiquitin-proteasome pathway is a critical
determinant for maintaining cellular homeostasis. Most intracellular proteins are degraded …

Site-specific proteasome inhibitors

AF Kisselev - Biomolecules, 2021 - mdpi.com
Proteasome is a multi-subunit protein degradation machine, which plays a key role in the
maintenance of protein homeostasis and, through degradation of regulatory proteins, in the …

Proteasome inhibitors as therapeutic agents: current and future strategies

JG Delcros, M Floc'h, C Prigent… - Current medicinal …, 2003 - ingentaconnect.com
In cells, protein degradation is a key pathway for the destruction of abnormal or damaged
proteins as well as for the elimination of proteins whose presence is no longer required …